Jörg‐Detlef Drenckhahn

Author

Also Known As

Drenckhahn, Jörg-Detlef, J D Drenckhahn, J. D. Drenckhahn, J.-D. Drenckhahn, J.D. Drenckhahn, Joerg-Detlef Drenckhahn, Jorg-Detlef Drenckhahn, Jörg-Detlef Drenckhahn, Jörg D. Drenckhahn, Jörg Drenckhahn

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Max Delbrück Center Charité - Universitätsmedizin Berlin University Hospital Münster Monash University University of Lübeck

About

Jörg‐Detlef Drenckhahn is an author at Max Delbrück Center specializing in medicine, cardiology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.1K
2	Cell Biology	2	2	188
3	Cellular Physiology	1	1	11
4	Emergency Medicine	1	1	174
5	Molecular Genetics	1	1	208

Jörg‐Detlef Drenckhahn

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Is a Fully Penetrant, Lethal Arrhythmic Disorder Caused by a Missense Mutation in the TMEM43 Gene Nancy D. Merner, Kathy Hodgkinson, Annika Haywood, The American Journal of Human Genetics CardiomyopathyHeart FailureTmem43 GeneCardiovascular DiseaseGenetics	2008	502
Mutations in Sarcomere Protein Genes in Left Ventricular Noncompaction Sabine Klaassen, Susanne Probst, Erwin Oechslin, Circulation	2008	447
Fine Mapping of the 1p36 Deletion Syndrome Identifies Mutation of PRDM16 as a Cause of Cardiomyopathy Anne-Karin Arndt, Sebastian Schäfer, Jörg‐Detlef Drenckhahn, The American Journal of Human Genetics CardiomyopathyGeneticsPathologyMolecular GeneticsDisease Gene Identification	2013	208
Compensatory Growth of Healthy Cardiac Cells in the Presence of Diseased Cells Restores Tissue Homeostasis during Heart Development Jörg‐Detlef Drenckhahn, Quenten Schwarz, Stephen P. Gray, Developmental Cell Regenerative MedicineCardiac MuscleCardiomyopathyDevelopmental BiologyCompensatory Growth	2008	177
The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5) Kathy Hodgkinson, Patrick S. Parfrey, Anne S. Bassett, Journal of the American College of Cardiology CardiomyopathyHeart FailureDevice TherapyCardiovascular DiseaseImplantable Cardioverter-defibrillator Therapy	2005	174
Disruption of the murine dynein light chain gene <i>Tcte3-3</i> results in asthenozoospermia Sajid Rashid, Paweł Grzmil, Jörg‐Detlef Drenckhahn, Reproduction	2009	29
Prenatal Mechanistic Target of Rapamycin Complex 1 (m TORC1) Inhibition by Rapamycin Treatment of Pregnant Mice Causes Intrauterine Growth Restriction and Alters Postnatal Cardiac Growth, Morphology, and Function M. Hennig, Saskia Fiedler, Christian Jux, Journal of the American Heart Association	2017	28
Impaired myocardial development resulting in neonatal cardiac hypoplasia alters postnatal growth and stress response in the heart Jörg‐Detlef Drenckhahn, Jette Strasen, K. Heinecke, Cardiovascular Research	2015	24
Activation of Peroxisome Proliferator–Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis Jarkko Hytönen, Olli Leppänen, Jan Hinrich Braesen, Arteriosclerosis Thrombosis and Vascular Biology	2016	24
Heart Development: Mitochondria in Command of Cardiomyocyte Differentiation Jörg‐Detlef Drenckhahn Developmental Cell Cardiac MuscleCardiomyopathyDevelopmental BiologyPhysiologyCardiac Progenitor Cells	2011	19

Page 1